Czech urology, 2016 (vol. 20), issue 3
Editorial
Editorial
Jan Krhut
Ces Urol 2016, 20(3):188 
Video
Laparoscopic nephropexy
Milan Hora, Kristýna Procházková, Alžběta Šobrová, Viktor Eret, Olga Dolejšová, Petr Stránský
Ces Urol 2016, 20(3):189-191
Hora M, Procházková K, Šorbová A, Eret V, Dolejšová O, Stránský P. Laparoscopic nephropexy. Objective: To present our contemporary technique of laparoscopic nephropexy. We follow data based on clinical studies of lower quality recommending the laparoscopic technique of suturing of renal capsule at convexity of kidney (1). Material, methods: Indications for surgery are symptomatic patients with proven nephroptosis on radiological examinations (mainly IVU). From 12/2004 until 7/2016, nephropexy was performed on 31 women. In 28 on the right side, two times on both sides and once on left. The right side nephropexy was twice combined with dismembered pyeloplasty....
OPEN RESECTION OF PAPILLARY RENAL CELL CARCINOMA CATEGORY cT2a
Kristýna Procházková, Milan Hora, Viktor Eret, Petr Stránský, Tomáš Ürge, Tomáš Pitra, Petr Hošek, Jiří Ferda, Ondřej Hes
Ces Urol 2016, 20(3):192-194
Procházková K, Hora M, Eret V, Stránský P, Ürge T, Pitra T, Hošek P, Ferda J, Hes O. Open resection of papillary renal cell carcinoma category cT2a. Introduction: Papillary renal cell carcinoma (pRCC) is the second most common renal tumour. The tumour has a characteristic appearance on preoperative CT/MR imaging, with typical extrarenal growth and a regular, cyst imitate (category Bosniak IIF-III), spherical shape (1, 2, 3, 4). These characteristics are most pronounced in pRCC type 1 according to Delahunt (5). This type of tumour also has the best prognosis in this group of tumours. Resection of the tumour is unambiguously the preferred...
Review article
A known (and unkown) HIV-positive patient in clinical urological practice
Marek Štefan
Ces Urol 2016, 20(3):195-203 | DOI: 10.48095/cccu2016033
Štefan M. A known (and unkown) HIV-positive patient in clinical urological practice Major statement: Which patients should be tested for HIV and how to manage HIV-positive patients in urological clinical practice. By immune system destruction, human immunodeficiency virus infection eventually leads to the death of affected patients. The prevalence of HIV infection in the Czech Republic is rising due to multiple causes, one of which is prolonged survival of patients treated with combined antiretroviral therapy. This has led to a dramatic decrease in the incidence of opportunistic infections and virus-related malignancies. Thus, the urologist...
Cystic tumors of the kidney
Tomáš Pitra, Kristýna Pivovarčíková, Ivan Trávníček, Kristýna Procházková, Ondřej Hes, Hynek Mírka, Radek Tupý, Milan Hora
Ces Urol 2016, 20(3):204-213 | DOI: 10.48095/cccu2016032
Pitra T, Pivovarčíková K, Trávníček I, Procházková K, Hes O, Mírka H, Tupý R, Hora M. Cystic tumors of the kidney. Major statement: Review dealing with clinical manifestation, diagnostic process and management of cystic tumors of the kidney. Review of literature. Introduction: A relatively small part of tumors of kidney is manifested as cystic tumors - 8% - based on our cohort of patients. Both benign and malignant lesions are included in this group. Such lesions have generally better prognosis than so-called solid tumors. Overview of cystic renal lesions: Typical representatives of tumors included in the cystic group are - multilocular...
Original paper
Cabazitaxel for the treatment of metastatic castration-resistant prostate cancer
Igor Richter, Josef Dvořák, Věra Hejzlarová, Eva Čermáková, Jiří Bartoš
Ces Urol 2016, 20(3):214-220 | DOI: 10.48095/cccu2016027
Richter I, Dvořák J, Hejzlarová V, Čermáková E, Bartoš J. Cabazitaxel for the treatment of metastatic castration-resistant prostate cancer. Major statement: Cabazitaxel is a new therapeutic option in patients with metastatic castration-resistant prostate cancer (mCRPC). We presented a retrospective evaluation of toxicity and efficacy in 14 patients with mCRPC treated by cabazitaxel Aim: A retrospective evaluation of efficacy and torerance of cabazitaxel in the treatment of metastatic castration-resistant prostate cancer (mCRPC). Methods: A total of 14 patients with mCRPC after previous treatment of docetaxel were evaluated....
Neoadjuvant chemotherapy in muscle-invasive urothelial bladder cancer: correlation of response with patients survival
Michal Staník, Alexander Poprach, Daniel Macík, Ivo Čapák, Jiří Jarkovský, Denisa Malúšková, Natália Marečková, Radek Lakomý, Jan Doležel
Ces Urol 2016, 20(3):221-228 | DOI: 10.48095/cccu2016031
Aims: Neoadjuvant chemotherapy (NAC) was shown to improve the overall survival in randomized trials. The aim of the study was to evaluate the frequency of response to NAC and the impact on prognosis of the disease. Methods: From January 2010 to October 2015 124 patients with bladder cancer underwent radical cystectomy and 41 of them (33 %) received NAC. Chemotherapy was indicated in cT3-4 or cN+ tumours, cT2N0 disease only in presence of risk factors like hydronephrosis or lymphovascular invasion. Glomerular filtration rate >50 ml/min and ECOG performance status ≤1 were used as chemotherapy eligibility criteria. Gemcitabine and cisplatin was...
Case report
Urinary incontinence in a child with a triplex ureter and ectopic ureter
Jaroslav Molčan
Ces Urol 2016, 20(3):229-234 | DOI: 10.48095/cccu2016028
Molčan J. Urinary incontinence in a child with a triplex ureter and ectopic ureter. Continuous leakage of urine despite simultaneous normal micturition can be a sign of an ectopic ureter in girls. The case of 6 year old girl who suffered from continuous daylight and night time urine leakage is reported. Diagnosis and treatment of the child was done at the Clinic of paediatric urology. In diagnostics, we used sonography, excretory urography, cystoscopy, vaginoscopy and retrograde ureteropyelography. We found a rarely occurring triplex ureter on the left side and a sub-sphincteric ectopic ureter - with outlet into urethra....
Minimally invasive treatment of a hemoragic complication after Robotic-assisted Radical Prostatectomy
Petra Hokůvová, Miroslav Štrbavý, Marek Broul, Filip Cihlář, Jan Schraml
Ces Urol 2016, 20(3):235-238 | DOI: 10.48095/cccu2016025
Hokůvová P, Štrbavý M, Broul M, Cihlář F, Schraml J. Minimally invasive treatment of a hemoragic complication after Robotic-assisted Radical Prostatectomy. The authors present a minimally invasive solution of a bleeding complication after robotic-assisted radical prostatectomy (RARP) for clinically localized adenocarcinoma. Post-operative bleeding was stopped radiologically by selective embolization. The patient was fully stable after surgery, without need of intensive care and dismissed on the fifth post-operative day in excellent condition.
Information
The 23rd Annual Conference of the Slovak Urological Society in Žilina, Slovakia, 15-17 June 2016.
Ivan Minčík
Ces Urol 2016, 20(3):239-244